OSFI issued a letter outlining how federally regulated banks should treat the new capital made available to small and medium-size enterprises (SME) through the recently announced government programs. The government of Canada announced, on March 27, 2020, that it is making additional investments to support Canadian businesses dealing with the economic impact of COVID-19. The OSFI letter sets out how these exposures should be treated by deposit-taking institutions under the Capital Adequacy Requirements and Leverage Requirements Guidelines.
The OSFI letter is addressed to banks, bank holding companies, and federally regulated trust and loan companies. OSFI has specified the following capital treatment for each program:
- Canada Emergency Business Account. Banks taking on these loans can exclude them from their risk-based capital and leverage ratios.
- New Export Development Canada loan guarantee for SMEs. Banks taking on these loans would treat the portion of the loan backed by the government as a sovereign exposure, with the remaining portion treated as a loan to the borrower. The entire amount of the loan would be included in the leverage ratio calculation.
- New Business Development Bank of Canada co-lending program for SMEs. Banks taking on these loans would need to account for the portion of the loan that they hold in their risk-based capital and leverage ratios.
By announcing the capital treatment for loans made through these programs, OSFI is providing timely direction for institutions, financial markets, and borrowers. These and other responsive regulatory adjustments—such as the adjustment of a number of regulatory capital, liquidity, and reporting requirements in the banking, insurance, and pensions sectors and the ongoing supervisory vigilance—ensure that the OSFI guidance is appropriate for these extraordinary circumstances while remaining risk-focused and forward-looking. OSFI will continue to look for ways to ensure that its capital and liquidity requirements are fit-for-purpose during these extraordinary circumstances.
Keywords: Americas, Canada, Banking, SME, COVID-19, Regulatory Capital, CAR Guidelines, Leverage Requirements Guideline, Basel III, OSFI
Previous ArticleHKMA Announces Deferral of Implementation of Final Basel III Package
The Prudential Regulation Authority (PRA) published the final policy statement PS21/21 on the leverage ratio framework in the UK. PS21/21, which sets out the final policy of both the Financial Policy Committee (FPC) and PRA
The Consumer Financial Protection Bureau (CFPB) proposed to amend Regulation B to implement changes to the Equal Credit Opportunity Act (ECOA) under Section 1071 of the Dodd-Frank Act.
The Prudential Regulation Authority (PRA) decided to maintain, at the 2019 levels, the buffer rates for the Other Systemically Important Institutions (O-SII) for another year, with no new rates to be set until December 2023.
The Financial Stability Board (FSB) published a progress report on implementation of its high-level recommendations for the regulation, supervision, and oversight of global stablecoin arrangements.
In a letter to the authorized deposit taking institutions, the Australian Prudential Regulation Authority (APRA) announced an increase in the minimum interest rate buffer it expects banks to use when assessing the serviceability of home loan applications.
The Committee on Payments and Market Infrastructures (CPMI) and the International Organization of Securities Commissions (IOSCO) are consulting on the preliminary guidance that clarifies that stablecoin arrangements should observe international standards for payment, clearing, and settlement systems.
The European Banking Authority (EBA) and the European Insurance and Occupational Pensions Authority (EIOPA) have set out their respective work priorities for 2022.
The Malta Financial Services Authority (MFSA) updated the guidelines on supervisory reporting requirements under the reporting framework 3.0, in addition to the reporting module on leverage under the common reporting (COREP) framework.
The European Commission (EC) published the Implementing Decision 2021/1753 on the equivalence of supervisory and regulatory requirements of certain third countries and territories for the purposes of the treatment of exposures, in accordance with the Capital Requirements Regulation or CRR (575/2013).
EC published the Implementing Regulation 2021/1751, which lays down implementing technical standards on uniform formats and templates for notification of determination of the impracticability of including contractual recognition of write-down and conversion powers.